Gastrointestinale virkninger ses hyppigere i begyndelsen af behandlingen, og hos de fleste patienter ophører de inden for nogle få uger, uden at behandlingen seponeres.
Gastrointestinal effects are more frequent at the beginning of therapy and resolve in most patients within a few weeks without the discontinuation of treatment.